ABOUT US INVESTMENT STRATEGY PORTFOLIO CONTACT Team Honorific President - Juan Abelló Gallo Executive President - Miguel Abelló Gamazo Investment Team: Alfredo Tennenbaum Casado Managing Director and Head of Strategic Investments Legal & Tax: Almudena De Egaña Huerta Head of Legal Administration: Francisco A. Toledo González Head of Administration Alvaro Garteiz Castellanos Managing Director and Head of Liquid Investments David García – Ganuza de Mier Head of Tax Miguel de la Fuente Álvarez Head of Treasury Borja Pinedo de Zúñiga y de Noriega Strategic Investments Pablo Compte Fernández Tax Department Ana Belén Guillén Carralón Head of Accounting Javier Párrizas Fernández Strategic Investments Loreto Hernando Martinez Lawyer Jaime Cortés Torres Strategic Investments Family Counsel: Pedro del Corro García-Lomas Senior Advisor and Member of the Family Counsel José Díaz-Rato Revuelta Secretary to the Board of Directors and Member of the Family Counsel

ABOUT US INVESTMENT STRATEGY PORTFOLIO CONTACT What makes us different + Family - owned investment firm with an institutional set-up + Patient capital and absolute investment flexibility + Versatile investor and roles + Value added to our partners and portfolio companies + Participative and supportive style + Long - standing successful track record. + Experienced team of professionals

ABOUT US INVESTMENT STRATEGY PORTFOLIO CONTACT The Abelló family 1919: Juan Abelló Pascual founds Fábrica de Productos Químicos y Farmacéuticos Abelló, by acquiring a small pharmacy in Madrid with adjacent laboratory where he started producing medicaments. 1933: First permit to import 400kg of alkaloids from India to produce codeine for Spain. 1949: Foundation of Antibióticos, S.A. 1966: Juan Abelló Gallo appointed Managing Director of the group. 1983: Disposal of Fábrica de Productos Químicos y Farmacéuticos Abelló to Merck. 1984: Increased stake in Antibióticos, another historical portfolio company. 1987: Disposal of Antibióticos and other family pharma assets (maintaining Alergia e Inmunología Abelló, S.A. and Alcaloides, S.A.) to Montedison. 1987: Acquisition of a relevant position in Banesto (today Santander). Juan Abelló Gallo appointed Vice-Chairman. Position sold in 1989. 1990: Foundation of Torreal. From 1990 to 2005, Torreal acted, mainly in Spain, as leading investor or local partner for foreign families or international players. Since 2005, Torreal started its international diversification. Currently, the majority of its portfolio is outside of Spain.